{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:23:16Z","timestamp":1783545796729,"version":"3.55.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009575","name":"Jacques und Gloria Gossweiler-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009575","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pilot Feasibility Stud"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Huntington\u2019s disease (HD) is an adult-onset genetic neurodegenerative condition\u00a0associated with cognitive decline, motor impairments, and emotional difficulties. Anxiety affects up to 71% of HD gene expansion carriers (i.e., those with the version of the gene that causes HD) and can negatively impact quality of life, worsen other HD symptoms, and increase suicide risk. Therefore, helping people with their anxiety should be a clinical priority. A significant evidence base now exists for low-cost talking therapies for anxiety, such as guided self-help, and with people with other neurodegenerative conditions (e.g., Parkinson\u2019s disease). However, this type of intervention has not been specifically assessed with HD gene expansion carriers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This protocol describes an exploratory randomised controlled feasibility study of a psychological intervention for anxiety\u00a0for HD gene expansion carriers. The 10 session guided self-help intervention\u00a0('GUIDE-HD') is based on a blend of second and third wave cognitive behavioural models of anxiety (cognitive behaviour therapy [CBT] and acceptance and commitment therapy [ACT]) and is adapted to meet the specific needs of an HD population. This study will compare guided self-help with treatment as usual (TAU), with 15 HD gene expansion carriers randomly allocated to each group. Participants will be recruited across the UK. Quantitative data will be collected pre-intervention, immediately post-intervention, 3-month post-intervention and 6-month post-intervention. Qualitative data will be collected at one\u00a0month post-intervention from participants, including HD carers. The data will be analysed to assess whether the current intervention and study design are feasible to progress to a larger randomised controlled trial. Feasibility has been defined in terms of recruitment rate, retention rate to both trial arms, intervention adherence, and acceptability of the intervention and measurement tools.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Given the lack of evidenced interventions to date to support the wellbeing of people with the expanded Huntington\u2019s gene, this study will assess the feasibility of progressing this particular intervention to a full trial. To try and increase the acceptability of the intervention, a number of stakeholders, including those affected by HD and in caring roles, have been fundamental to the creation of the intervention (e.g., therapy manual, planned therapy process) to date.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Trial ID:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.isrctn.com\/ISRCTN47330596\">ISRCTN47330596<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                    <jats:p>Date registered: 28\/09\/2022.<\/jats:p>\n                    <jats:p>Protocol version and date: Version 2, 09\/06\/22.<\/jats:p>\n                    <jats:p>Trial sponsor organisation and contact: Leicestershire Partnership NHS Trust (Dave Clarke).<\/jats:p>\n                    <jats:p>Role of sponsor: Overall responsibility for the conduct and governance of the trial.<\/jats:p>\n                    <jats:p>Role of funder: Review of initial research proposal.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40814-023-01364-5","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T04:03:19Z","timestamp":1694491399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Guided self-help for anxiety among Huntington\u2019s disease gene expansion carriers (GUIDE-HD) compared to treatment as usual: a randomised controlled feasibility trial"],"prefix":"10.1186","volume":"9","author":[{"given":"Maria","family":"Dale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona J. R.","family":"Eccles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Melvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaynah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8129-6151","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Zarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5071-4077","authenticated-orcid":false,"given":"Jane","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,12]]},"reference":[{"key":"1364_CR1","doi-asserted-by":"crossref","unstructured":"Roos R A C. Huntington\u2019s disease: a clinical review. Orphanet J Rare Dis. BioMed Central Ltd; 2010;5:40.","DOI":"10.1186\/1750-1172-5-40"},{"key":"1364_CR2","doi-asserted-by":"publisher","unstructured":"Fusilli C, Migliore S, Mazza T, Consoli F, De Luca A, Barbagallo G, et al. Biological and clinical manifestations of juvenile Huntington\u2019s disease: a retrospective analysis. Lancet Neurol. Elsevier Ltd; 2018;17:986\u201393. https:\/\/doi.org\/10.1016\/S1474-4422(18)30294-1.","DOI":"10.1016\/S1474-4422(18)30294-1"},{"key":"1364_CR3","doi-asserted-by":"crossref","unstructured":"Bates G, Tabrizi S, Jones L. Huntington\u2019s disease. Bates GP, Tabrizi SJ, Jones L, editors. New York: Oxford University Press; 2014.","DOI":"10.1093\/med\/9780199929146.001.0001"},{"key":"1364_CR4","doi-asserted-by":"publisher","unstructured":"Eccles FJR, Craufurd D, Smith A, Davies R, Glenny K, Homberger M, et al. Experiences of mindfulness-based cognitive therapy for premanifest Huntington\u2019s disease. J Huntingtons Dis. IOS Press; 2021;10:277\u201391. https:\/\/doi.org\/10.3233\/JHD-210471.","DOI":"10.3233\/JHD-210471"},{"key":"1364_CR5","doi-asserted-by":"crossref","unstructured":"Peixoto C, Rego D, Bicho M, Coelho J, Medeiros H. Psychiatric symptoms in Huntington\u2019s disease. Eur Psychiatry. 2021;64:S254\u20135.","DOI":"10.1192\/j.eurpsy.2021.682"},{"key":"1364_CR6","doi-asserted-by":"publisher","unstructured":"van der Meer LB, van Duijn E, Giltay EJ, Tibben A. Do attachment style and emotion regulation strategies indicate distress in predictive testing? J Genet Couns. 2015;24:862\u201371. https:\/\/doi.org\/10.1007\/s10897-015-9822-z.","DOI":"10.1007\/s10897-015-9822-z"},{"key":"1364_CR7","doi-asserted-by":"publisher","unstructured":"Simpson J, Zarotti N, Varey S, Anestis E, Holland C, Murray C, et al. \u2018It\u2019s a double whammy\u2019: a qualitative study of illness uncertainty in individuals with Parkinson\u2019s disease in the context of COVID-19. Chronic Illn. 2021;1\u201326. https:\/\/doi.org\/10.1177\/17423953211043101.","DOI":"10.1177\/17423953211043101"},{"key":"1364_CR8","doi-asserted-by":"crossref","unstructured":"Simpson J, McMillan H, Reeve D. Reformulating psychological difficulties in people with Parkinson\u2019s disease: the potential of a social relational approach to disablism. Parkinson's Dis. Hindawi; 2013;2013.","DOI":"10.1155\/2013\/608562"},{"key":"1364_CR9","doi-asserted-by":"publisher","unstructured":"Eccles FJR, Sowter N, Spokes T, Zarotti N, Simpson J. Stigma, self-compassion, and psychological distress among people with Parkinson\u2019s. Disabil Rehabil. Taylor & Francis; 2022.\u00a0https:\/\/doi.org\/10.1080\/09638288.2022.2037743.","DOI":"10.1080\/09638288.2022.2037743"},{"key":"1364_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1176\/appi.neuropsych.14100265","volume":"27","author":"M Dale","year":"2015","unstructured":"Dale M, van Duijn E. Anxiety in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2015;27:262\u201371.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1364_CR11","doi-asserted-by":"publisher","first-page":"474\u2013","DOI":"10.1007\/s11910-011-0215-x","volume":"11","author":"Paulsen JS","year":"2011","unstructured":"JS Paulsen. Cognitive impairment in Huntington disease: diagnosis and treatment. Curr Neurol Neurosci Rep. 2011;11:474--83 2011\/08\/24.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1364_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/mdc3.12376","volume":"4","author":"M Underwood","year":"2017","unstructured":"Underwood M, Bonas S, Dale M. Huntington\u2019s disease: prevalence and psychological indicators of pain. Mov Disord Clin Pract. 2017;4:198\u2013204.","journal-title":"Mov Disord Clin Pract"},{"key":"1364_CR13","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10880-009-9168-5","volume":"16","author":"MP McCabe","year":"2009","unstructured":"McCabe MP, Firth L, O\u2019Connor E. A comparison of mood and quality of life among people with progressive neurological illnesses and their caregivers. J Clin Psychol Med Settings. 2009;16:355\u201362.","journal-title":"J Clin Psychol Med Settings"},{"key":"1364_CR14","doi-asserted-by":"publisher","unstructured":"Thorley EM, Iyer RG, Wicks P, Curran C, Gandhi SK, Abler V, et al. Understanding how chorea affects health-related quality of life in Huntington disease: an online survey of patients and caregivers in the United States. Patient. Springer International Publishing; 2018;11:547\u201359. https:\/\/doi.org\/10.1007\/s40271-018-0312-x.","DOI":"10.1007\/s40271-018-0312-x"},{"key":"1364_CR15","doi-asserted-by":"publisher","first-page":"E1643","DOI":"10.1212\/WNL.0000000000007244","volume":"92","author":"A McGarry","year":"2019","unstructured":"McGarry A, McDermott MP, Kieburtz K, Fung WLA, Mccusker E, Peng J, et al. Risk factors for suicidality in Huntington disease: an analysis of the 2CARE clinical trial. Neurology. 2019;92:E1643\u201351.","journal-title":"Neurology"},{"key":"1364_CR16","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1176\/appi.neuropsych.17080173","volume":"30","author":"NE Fritz","year":"2018","unstructured":"Fritz NE, Boileau NR, Stout JC, Ready R, Perlmutter JS, Paulsen JS, et al. Relationships among apathy, health-related quality of life, and function in Huntington\u2019s disease. J Neuropsychiatry Clin Neurosci. 2018;30:194\u2013201.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1364_CR17","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1176\/appi.neuropsych.17040086","volume":"30","author":"AMY Goh","year":"2018","unstructured":"Goh AMY, You E, Perin S, Clay FJ, Loi S, Ellis K, et al. Predictors of workplace disability in a premanifest Huntington\u2019s disease cohort. J Neuropsychiatry Clin Neurosci. 2018;30:115\u201321.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1364_CR18","doi-asserted-by":"publisher","unstructured":"Zarotti N, Dale M, Eccles F, Simpson J. Psychological interventions for people with Huntington\u2019s disease: a call to arms. J Huntingtons Dis. IOS Press; 2020;9:231\u201343. https:\/\/doi.org\/10.3233\/JHD-200418.","DOI":"10.3233\/JHD-200418"},{"key":"1364_CR19","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3233\/JHD-180293","volume":"7","author":"KE Anderson","year":"2018","unstructured":"Anderson KE, Van Duijn E, Craufurd D, Drazinic C, Edmondson M, Goodman N, et al. Clinical management of neuropsychiatric symptoms of Huntington disease: expert-based consensus guidelines on agitation, anxiety, apathy, psychosis and sleep disorders. J Huntingtons Dis. 2018;7:355\u201366.","journal-title":"J Huntingtons Dis"},{"key":"1364_CR20","doi-asserted-by":"crossref","unstructured":"Coull G, Morris PG. The clinical effectiveness of CBT-based guided self-help interventions for anxiety and depressive disorders: a systematic review. Psychol Med. 2011\/06\/15. Cambridge University Press; 2011;41:2239\u201352.","DOI":"10.1017\/S0033291711000900"},{"key":"1364_CR21","doi-asserted-by":"crossref","unstructured":"Dobkin RD, Interian A, Durland JL, Gara MA, Menza MA. Personalized telemedicine for depression in Parkinson\u2019s disease: a pilot trial. J Geriatr Psychiatry Neurol. 2018\/06\/28. United States: Sage Publications; 2018;31:171\u20136.","DOI":"10.1177\/0891988718783274"},{"key":"1364_CR22","doi-asserted-by":"crossref","unstructured":"Ehde DM, Elzea JL, Verrall AM, Gibbons LE, Smith AE, Amtmann D. Efficacy of a telephone-delivered self-management intervention for persons with multiple sclerosis: a randomized controlled trial with a one-year follow-up. Arch Phys Med Rehabil. 2015\/08\/10. United States: W.B. Saunders; 2015;96:1945.","DOI":"10.1016\/j.apmr.2015.07.015"},{"key":"1364_CR23","doi-asserted-by":"publisher","unstructured":"Zarotti N, Eccles F, Broyd A, Longinotti C, Mobley A, Simpson J. Third wave cognitive behavioural therapies for people with multiple sclerosis: a scoping review. Disabil Rehabil. Taylor & Francis; 2022;1\u201316. https:\/\/doi.org\/10.1080\/09638288.2022.2069292.","DOI":"10.1080\/09638288.2022.2069292"},{"key":"1364_CR24","doi-asserted-by":"publisher","unstructured":"Ciriegio AE, Watson KH, Pfalzer AC, Hale L, Huitz E, Moroz S, et al. Inhibitory control, working memory and coping with stress: associations with symptoms of anxiety and depression in adults with Huntington\u2019s disease. Neuropsychology. 2022;36:288\u201396. https:\/\/doi.org\/10.1037\/neu0000793.","DOI":"10.1037\/neu0000793"},{"key":"1364_CR25","doi-asserted-by":"publisher","unstructured":"Theed R, Eccles FJRR, Simpson J. Understandings of psychological difficulties in people with the Huntington\u2019s disease gene and their expectations of psychological therapy. Psychol Psychother Theory, Res Pract. BMJ Publishing Group Ltd; 2018;91:216\u201331. https:\/\/doi.org\/10.1111\/papt.12157.","DOI":"10.1111\/papt.12157"},{"key":"1364_CR26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/wps.20884","volume":"20","author":"SC Hayes","year":"2021","unstructured":"Hayes SC, Hofmann SG. \u201cThird-wave\u201d cognitive and behavioral therapies and the emergence of a process-based approach to intervention in psychiatry. World Psychiatry. 2021;20:363\u201375.","journal-title":"World Psychiatry"},{"key":"1364_CR27","doi-asserted-by":"publisher","DOI":"10.32388\/WW04E6","author":"R West","year":"2020","unstructured":"West R, Michie S. A brief introduction to the COM-B model of behaviour and the PRIME Theory of motivation. Qeios. 2020. https:\/\/doi.org\/10.32388\/WW04E6.","journal-title":"Qeios"},{"key":"1364_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/pst.185","volume":"4","author":"SA Julious","year":"2005","unstructured":"Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287\u201391.","journal-title":"Pharm Stat"},{"key":"1364_CR29","doi-asserted-by":"crossref","unstructured":"Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology. 1979;29:1\u20133. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/154626.","DOI":"10.1212\/WNL.29.1.1"},{"key":"1364_CR30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.","edition":"5"},{"key":"1364_CR31","doi-asserted-by":"publisher","unstructured":"Nasreddine Z, Phillips N. The Montreal Cognitive Assessment, MoCA\u202f: a brief screening tool for mild cognitive impairment. J. 2005;53:695\u20139. https:\/\/doi.org\/10.1111\/j.1532-5415.2005.53221.x\/full.","DOI":"10.1111\/j.1532-5415.2005.53221.x\/full"},{"key":"1364_CR32","doi-asserted-by":"publisher","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50\u20135. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x.","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"1364_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x","journal-title":"Acta Psychiatr Scand."},{"key":"1364_CR34","doi-asserted-by":"publisher","unstructured":"Snaith RP, Constantopoulos AA, Jardine MY, McGuffin P. A clinical scale for the self-assessment of irritability. Br J Psychiatry. 1978;132:164\u201371. https:\/\/doi.org\/10.1192\/bjp.132.2.164.","DOI":"10.1192\/bjp.132.2.164"},{"key":"1364_CR35","doi-asserted-by":"crossref","unstructured":"Hocaoglu MB, Gaffan EA, Ho AK. The Huntington\u2019s Disease health-related Quality of Life questionnaire (HDQoL): a disease-specific measure of health-related quality of life. Clin Genet. 2012;81:117\u201322.","DOI":"10.1111\/j.1399-0004.2011.01823.x"},{"key":"1364_CR36","doi-asserted-by":"publisher","unstructured":"Dale M, Maltby J, Freire-Patino D, Kiani R. Abstracts from HSG 2018. Development of a psychological model of anxiety among those at-risk and those who have tested positive for Huntington disease. Neurotherapeutics. 2018. https:\/\/doi.org\/10.1007\/s13311-017-0579-y.","DOI":"10.1007\/s13311-017-0579-y"},{"key":"1364_CR37","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1207\/s15327558ijbm0401_6","volume":"4","author":"CS Carver","year":"1997","unstructured":"Carver CS. You want to measure coping but your protocol\u2019s too long: consider the brief COPE. Int J Behav Med. 1997;4:92\u2013100 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16250744.","journal-title":"Int J Behav Med."},{"key":"1364_CR38","doi-asserted-by":"publisher","unstructured":"Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary psychometric properties of the Acceptance and Action Questionnaire\u2013II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. Elsevier B.V.; 2011;42:676\u201388. https:\/\/doi.org\/10.1016\/j.beth.2011.03.007.","DOI":"10.1016\/j.beth.2011.03.007"},{"key":"1364_CR39","doi-asserted-by":"crossref","unstructured":"Richie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. London & New York: Routledge; 1994. p. 173\u201394.","DOI":"10.4324\/9780203413081_chapter_9"},{"key":"1364_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1471-2288-13-117","volume":"13","author":"NK Gale","year":"2013","unstructured":"Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol. 2013;13:117 https:\/\/doi.org\/10.1186\/1471-2288-13-117.","journal-title":"BMC Med Res Methodol."},{"key":"1364_CR41","doi-asserted-by":"publisher","unstructured":"British Psychological Society. Psychological interventions for people with Huntington\u2019s disease, Parkinson\u2019s disease, motor neurone disease, and multiple sclerosis: evidence-based guidance. Leicester; 2021. https:\/\/doi.org\/10.53841\/bpsrep.2021.rep143.","DOI":"10.53841\/bpsrep.2021.rep143"},{"key":"1364_CR42","unstructured":"Simpson J, Eccles FJ, Zarotti N. Extended evidence-based guidance on psychological interventions for psychological difficulties in individuals with Huntington\u2019s disease, Parkinson\u2019s disease, motor neurone disease, and multiple sclerosis. 2021. https:\/\/doi.org\/10.5281\/zenodo.4593882."},{"key":"1364_CR43","doi-asserted-by":"publisher","unstructured":"Zarotti N, Dale M, Eccles FJR, Simpson J. More than just a brain disorder: a five-point manifesto for psychological care for people with Huntington\u2019s disease. J Pers Med. 2022;12:64. https:\/\/doi.org\/10.3390\/jpm12010064.","DOI":"10.3390\/jpm12010064"},{"key":"1364_CR44","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.cpr.2013.07.003","volume":"33","author":"E Hans","year":"2013","unstructured":"Hans E, Hiller W. A meta-analysis of nonrandomized effectiveness studies on outpatient cognitive behavioral therapy for adult anxiety disorders. Clin Psychol Rev Elsevier Ltd. 2013;33:954\u201364 https:\/\/doi.org\/10.1016\/j.cpr.2013.07.003.","journal-title":"Clin Psychol Rev. Elsevier Ltd"}],"container-title":["Pilot and Feasibility Studies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40814-023-01364-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40814-023-01364-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T10:56:41Z","timestamp":1700477801000},"score":1,"resource":{"primary":{"URL":"https:\/\/pilotfeasibilitystudies.biomedcentral.com\/articles\/10.1186\/s40814-023-01364-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1364"],"URL":"https:\/\/doi.org\/10.1186\/s40814-023-01364-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2373607\/v1","asserted-by":"object"}]},"ISSN":["2055-5784"],"issn-type":[{"value":"2055-5784","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,12]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the UK NHS Leicester South Research Ethics Committee (IRAS number 304674). Any changes to the protocol will be submitted to the REC for further approvals. Participants with HD and carers are consented at one time point in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"No participant identifiable information will be published.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}